Literature DB >> 14674062

Splenic fine needle aspiration and core biopsy. A review of 49 cases.

Aseem Lal1, Reshma Ariga, Paolo Gattuso, Albert A Nemcek, Ritu Nayar.   

Abstract

OBJECTIVE: To analyze the authors' experience with splenic fine needle aspiration (sFNA) and splenic core biopsy (sCB) and to examine their roles in patients with splenomegaly or splenic mass lesions. STUDY
DESIGN: A total of 56 sFNAs and/or sCBs were performed on 49 patients for neoplastic and nonneoplastic indications. Both sFNAs and sCBs were performed in 21 (38%) cases, sFNAs alone in 26 (46%) and sCBs only in 9 (16%). Cytologic findings were evaluated for specimen adequacy, diagnosis and use of ancillary techniques. Cytologic diagnosis was compared with histology on subsequent splenectomy or bone marrow biopsy, when available.
RESULTS: There were a total of 33 males and 16 females (aged 30-82 years) in the study. Radiologic findings were single or multiple masses (42), fluid collection (3) or diffuse splenomegaly (4). The cytologic diagnosis was neoplastic process in 12 (25%), nonneoplastic in 32 (65%) and inadequate specimen in 5 (10%). The procedure was adequate for diagnosis in 44 (90%) patients. Cytologic diagnosis correlated with subsequent histology in all cases where tissue diagnosis was available. Major complications occurred in 3 (6%) patients, including hemorrhage, pseudoaneurysm and hypotension. Five other patients (10%) had minor complications. The number of passes, inclusion of sCB and repeat procedures were not associated with an increased risk of complications.
CONCLUSION: sFNA and sCB have excellent diagnostic accuracy in both neoplastic and nonneoplastic splenic disorders. While the overall complication rate is significant, major complications of the procedure are uncommon.

Entities:  

Mesh:

Year:  2003        PMID: 14674062     DOI: 10.1159/000326667

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  6 in total

1.  Fever of unknown origin revealed to be primary splenic lymphoma: A rare case report with review of the literature.

Authors:  Pan-Ge Sun; Bei Cheng; Jin-Feng Wang; Ping He
Journal:  Mol Clin Oncol       Date:  2016-12-14

2.  CD30 and Epstein-Barr virus RNA expression in sclerosing angiomatoid nodular transformation of spleen.

Authors:  Ilan Weinreb; Denis Bailey; Donna Battaglia; Meagan Kennedy; Bayardo Perez-Ordoñez
Journal:  Virchows Arch       Date:  2007-05-10       Impact factor: 4.064

3.  Spleen rupture due to primary angiosarcoma: a case report.

Authors:  Ioannis M Koutelidakis; Panagiotis Z Tsiaousis; Basilios Th Papaziogas; Aristeides G Patsas; Stefanos K Atmatzidis; Konstantinos S Atmatzidis
Journal:  J Gastrointest Cancer       Date:  2008-11-19

4.  Subtotal splenectomy for splenomegaly in cirrhotic patients.

Authors:  Haibo Chu; Xiaofang Liu; Jianhua Zhao; Yongbo Xu; Lei Wang; Tao Wang; Wenjun Guo; Shengming Zhang; Xiaoji Zhu
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

5.  A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile.

Authors:  Linping Cao; Jiawei Hong; Yacong Wang; Jun Yu; Ruobing Ma; Jia Li; Jian Wu; Shusen Zheng
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Primary Splenic Angiosarcoma with Liver Metastasis: A Rare Neoplasm Diagnosed on Fine-needle Aspiration Cytology and Cell Block Immunocytochemistry.

Authors:  Saniya Sharma; Priya Singh; Pankaj Gupta; Anupam Lal; Radhika Srinivasan
Journal:  J Cytol       Date:  2018 Apr-Jun       Impact factor: 1.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.